Detalles de la búsqueda
1.
Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.
N Engl J Med
; 384(24): 2273-2282, 2021 06 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33882218
2.
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023.
MMWR Morb Mortal Wkly Rep
; 72(2): 39-43, 2023 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36634021
3.
Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months-5 Years - United States, June 17, 2022-May 7, 2023.
MMWR Morb Mortal Wkly Rep
; 72(23): 621-626, 2023 06 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37289661
4.
Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021.
Ann Intern Med
; 175(4): 513-522, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35038274
5.
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years - United States, March 29, 2022-July 10, 2022.
MMWR Morb Mortal Wkly Rep
; 71(30): 971-976, 2022 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35900925
6.
Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5-11 Years - United States, May 17-July 31, 2022.
MMWR Morb Mortal Wkly Rep
; 71(33): 1047-1051, 2022 Aug 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35980875
7.
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years - United States, August 31-October 23, 2022.
MMWR Morb Mortal Wkly Rep
; 71(44): 1401-1406, 2022 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36327162
8.
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022.
MMWR Morb Mortal Wkly Rep
; 71(7): 249-254, 2022 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35176008
9.
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022.
MMWR Morb Mortal Wkly Rep
; 71(9): 347-351, 2022 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35239637
10.
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022.
MMWR Morb Mortal Wkly Rep
; 71(28): 899-903, 2022 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35834416
11.
The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022.
MMWR Morb Mortal Wkly Rep
; 71(11): 416-421, 2022 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35298454
12.
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
JAMA
; 327(4): 331-340, 2022 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35076665
13.
Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021.
MMWR Morb Mortal Wkly Rep
; 70(39): 1379-1384, 2021 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34591835
14.
Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021.
MMWR Morb Mortal Wkly Rep
; 70(18): 685-688, 2021 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33956781
15.
COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021.
MMWR Morb Mortal Wkly Rep
; 70(5152): 1755-1760, 2021 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34968370
16.
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021.
MMWR Morb Mortal Wkly Rep
; 70(18): 680-684, 2021 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33956784
17.
COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021.
MMWR Morb Mortal Wkly Rep
; 70(31): 1053-1058, 2021 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34351881
18.
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
MMWR Morb Mortal Wkly Rep
; 70(32): 1094-1099, 2021 Aug 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34383735
19.
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.
JAMA
; 325(24): 2448-2456, 2021 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33929487
20.
Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
JAMA
; 326(14): 1390-1399, 2021 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34477808